Exscientia has signed up another big pharma partner for its artificial intelligence (AI) based drug discovery platform, this The post BMS embraces AI drug discovery with...
An open question is whether and when booster shots against Covid-19 will be necessary...
Dr. Deshayne Fell of CHEO Research Institute and University of Ottawa leads Ontario portion by studying BORN baby registry and province’s vaccination registry Credit: University of...
Four-month TB therapy proves as effective as 6-month standard regimen Credit: National Institute of Allergy and Infectious Diseases (NIAID) SAN ANTONIO (May 19, 2021) — Four...
In a rare move, the FDA has publicly accused US biotech CytoDyn of misrepresenting clinical trial results...
Over the last couple of months, we’ve lost two of the most prominent people in biopharma. José Baselga and John Martin achieved wonderful things in their...
Offering incentives to encourage good health behavior isn't new, but it does raise concerns. A behavioral scientist explains how rewarding those taking a shot need not...
With questions about the safety of COVID vaccines coming to the forefront, the need for safe mRNA vaccine alternatives is coming into the limelight. Although Mountain...
The pharmaceutical market is expected to increase in value, meaning there are plenty of opportunities for investing in pharmaceutical stocks. The post Why Consider Investing in...
The U.S. Food and Drug Administration published a “Statement on Leronlimab,” CytoDyn’s monoclonal antibody that was initially being developed for HIV and cancer before the company...
First of all, we are having a bit of a crisis with our crisis. As we appear to be moving into yet another wave of COVID-19...
Each year in January, it is relevant to look back on the activities of FDA during the course of the previous year and look at how...
Governments and companies are using incentives in hopes of getting more Americans to get a COVID-19 shot. A behavioral economist explains how they work.
Pfizer's Covid-19 vaccine generates antibody responses three-and-a-half times larger in older people when a second dose is delayed to 12 weeks after the first, a British...
Desperate Indian Communities Embrace Anti-Malaria Drugs To Protect Against COVID Surge For the past month and a half, the international community has watched in horror as...
Looking for penny stocks to buy in May 2021? Here's some watchlist inspiration The post Top Penny Stocks For Your May Watchlist? Check These 5 Out...
Giving a first dose of Covid-19 vaccine but delaying a second dose among people younger than 65 could lead to fewer people dying of the disease,...
A second-generation Covid-19 vaccine developed by CureVac and GlaxoSmithKline – designed to protect against coronavirus variants – produced a high level of immune response in a...
Experienced executives fill senior roles in business development, M&A, clinic operations and design, and corporate communications Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a...
Which gene therapy stocks should be on investors' radar? Here are five companies developing a wide range of gene therapy products. The post 5 Gene Therapy...
Partnership Aimed at Delivering Psychedelic Capsule for Dosing Study in Human Clinical Trial Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care...
Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and...
Usually, biopharma stocks are inclined to surge or crash based on regulatory decisions or the outcome of clinical trials. More unusual is for shares of one...
Each state has its own rules for which vaccines kids must have to attend school and the reasons students can opt out.
Numinus and Multidisciplinary Association for Psychedelic Studies collaboration will conduct follow-on Compassionate Access trial in real-world setting in Vancouver, Canada Numinus Wellness Inc. (“Numinus” or the...
The process will take months, if it's even approved. But just the threat of waiving intellectual property rights could spur faster action.
Children two to five years of age can benefit from lumacaftor/ivacaftor treatment for up to 120 weeks Credit: Children’s Hospital Colorado Children ages two to five...
Which penny stocks should you know about in 2021? Take a look at these 3 The post 3 Penny Stocks That Investors Need to Watch In...
Israeli company Kadimastem is developing regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells The post Tackling diabetes & ALS with cell...
How do medical devices get approved? Learn about the FDA's intricate process for classifying and regulating these products in the US. The post How Do Medical...